Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Solo Pace Fusion System (SOLOFUSE1)

K-Number: K252674 · 2026-01-09

Decision Date2026-01-09
Product CodeDQX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Solo Pace Fusion System (SOLOFUSE1) is a medical device manufactured by Solo Pace, Inc.. It received FDA 510(k) clearance on 2026-01-09 under approval number K252674. The device is classified under product code DQX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Solo Pace Fusion System (SOLOFUSE1)?

Solo Pace Fusion System (SOLOFUSE1) is a medical device that received FDA 510(k) clearance on 2026-01-09. It is manufactured by Solo Pace, Inc.. The 510(k) number is K252674.

When was Solo Pace Fusion System (SOLOFUSE1) approved by the FDA?

Solo Pace Fusion System (SOLOFUSE1) received FDA 510(k) clearance on 2026-01-09, under approval number K252674.

What company makes Solo Pace Fusion System (SOLOFUSE1)?

Solo Pace Fusion System (SOLOFUSE1) is manufactured by Solo Pace, Inc..

What is the FDA product code for Solo Pace Fusion System (SOLOFUSE1)?

The FDA product code for Solo Pace Fusion System (SOLOFUSE1) is DQX.

Related Clinical Trials

Other Devices by Solo Pace, Inc.

Related Devices (Code: DQX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.